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Abstract
Background: Observational studies have shown that tobacco and alcohol use co-occur,
but it is not clear whether this relationship is causal.
Methods: Using data from the Avon Longitudinal Study of Parents and Children
(ALSPAC) and UK Biobank, we used observational methods to test the hypothesis that
smoking heaviness increases alcohol consumption. Mendelian randomization (MR) ana-
lyses were then used to test the causal relationship between smoking heaviness and al-
cohol consumption using 55 967 smokers from four European studies [ALSPAC, The
Nord-Trøndelag Health Study (HUNT), the Copenhagen General Population Study
(CGPS) and UK Biobank]. MR analyses used rs1051730/rs16969968 as a genetic proxy for
smoking heaviness.
Results: Observational results provided evidence of an association between cigarettes
per day and weekly alcohol consumption (increase in units of alcohol per additional cig-
arette smoked per day ¼ 0.10, 95% confidence interval (CI) 0.05 to 0.15, P  0.001 in
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ALSPAC; and 0.48, 95% CI 0.45 to 0.52, P  0.001 in UK Biobank). However, there was
little evidence for an association between rs1051730/rs16969968 and units of alcohol con-
sumed per week across ALSPAC, HUNT, CGPS and UK Biobank (standard deviation in-
crease in units of alcohol per additional copy of the risk allele ¼ –0.004, 95% CI –0.023 to
0.016, P¼0.708, I2 ¼ 51.9%). We had 99% and 88% power to detect a change of 0.03 and
0.02 standard deviation units of alcohol per additional copy of the risk allele,
respectively.
Conclusions: Previously reported associations between smoking and alcohol are unlikely
to be causal, and may be the result of confounding and/or reverse causation. This has im-
plications for public health research and intervention research.
Key words: Mendelian randomization, licit drugs, ALSPAC, HUNT, CGPS, UK Biobank
Introduction
Smoking and alcohol are among the most important pre-
ventable causes of morbidity and mortality.1–4 Many stud-
ies have examined the relationship between tobacco and
alcohol use, with several of these focusing on smoking as a
risk factor for later alcohol use in both adolescence5–11 and
adulthood.12–16 However, current evidence is inconsistent
and the observational data used in such studies are difficult
to interpret due to the potential for unmeasured confound-
ing and reverse causation. Determining whether there is a
causal association between tobacco and alcohol use is im-
portant in the attempt to reduce the use of these drugs, as
one could use prevention of tobacco use as a means of
reducing alcohol misuse.
Mendelian randomization (MR) uses genetic variants
known to be associated with an exposure of interest as a
method of testing whether there is a causal association be-
tween exposure and disease.17 MR is based on three as-
sumptions. First, the genetic instrument being used must be
associated with the exposure of interest. Second, the genetic
instrument must only influence the outcome through the
exposure of interest. Third, the genetic instrument cannot
be associated with any factors that confound the relation-
ship between the exposure and the outcome.17 If the as-
sumptions of MR hold, genetic variants associated with an
exposure of interest should be independent of confounding
factors.18 Furthermore, as genotype is determined at
conception, it cannot be influenced by any stage of the dis-
ease process and therefore estimates cannot be the result of
reverse causation.17,18
We hypothesized that a genetic determinant of smoking
phenotypes would be associated with increased levels of al-
cohol use and would therefore provide evidence of a causal
relationship (MR). To test this, we first assessed the relation-
ship between heaviness of smoking and weekly alcohol con-
sumption using observational methods. Data from the Avon
Longitudinal Study of Parents and Children (ALSPAC) and
UK Biobank were used. In MR analyses, we used two single-
nucleotide polymorphisms (SNPs) in the nicotine acetylcho-
line receptor gene cluster (CHRNA5-CHRNA3-CHRNB4):
rs1051730 and rs16969968, which are highly correlated and
therefore can be used interchangeably.19 The rs16969968
SNP is a missense mutation that codes for a change in amino
acid from aspartate to asparagine in the a5 nAChR subunit
protein and is therefore of functional significance.
Conversely, rs1051730 is a coding synonymous variant and
is more likely to act as a proxy for a functional SNP.20 These
variants have been shown to be robustly associated with the
number of cigarettes consumed per day21–26 and have previ-
ously been used in MR studies.27–35 MR analyses were
carried out using four European cohorts [ALSPAC, the
Nord-Trøndelag Health Study (HUNT), the Copenhagen
General Population Study (CGPS) and UK Biobank] with re-
sults from all studies being meta-analysed.
Key Messages
• Observational studies have shown consistent strong evidence for an association between tobacco and alcohol use.
• It has been suggested that reductions in tobacco use can be used as an intervention target for alcohol.
• Our study suggests that heaviness of smoking does not causally influence level of alcohol consumption.
• It is likely that previous findings were the subject of confounding, reverse causation or bias.
• These findings could have implications for targeting smoking behaviour in interventions.
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Methods
Study populations
Four European cohort studies were utilized in this analysis
(ALSPAC, HUNT, CGPS and UK Biobank). ALSPAC is a
longitudinal birth cohort study situated in south-west
England that recruited more than 14 000 pregnant women
between 1991 and 1992.36,37 HUNT invited individuals in
Nord-Trøndelag County in Norway who were aged 20
years or older between 1995 and 1997 to take part in the
second wave of the study, and successfully recruited
65 215 individuals.38,39 CGPS is a study comprising ran-
domly selected Copenhagen residents aged 20–100 years.27
UK Biobank recruited over 500 000 men and women (aged
37–73 years) between 2006 and 2010.40 Full description of
each of the cohorts can be found in Supplementary
Methods, available as Supplementary Data at IJE online.
Phenotypic measures
Smoking
Cigarettes per day in individuals who reported smoking
was a continuous variable—a measure that has previously
shown association with rs16969968/rs1051730.23,41,42 In
ALSPAC, these data were collected during pregnancy (18
weeks’ gestation), but addressed regular smoking status
pre-pregnancy. In UK Biobank, participants were asked
about current and past smoking status during the baseline
computer-administered questionnaire. Individuals were
classed as current, former or never smokers. Individuals re-
porting regular use of pipes or cigars were excluded from
analyses.
Alcohol
Alcohol consumption was a continuous measure of units
of alcohol consumed per week, derived from the reporting
of frequency of alcohol consumption. Different questions
were asked in each of the four cohorts but all allowed the
calculation of average weekly intake in units. Further in-
formation on the derivation of this variable is provided in
Supplementary Table 1, available as Supplementary Data
at IJE online. Non-drinkers were excluding from analyses.
Confounders
Potential confounders for the observational analysis (con-
ducted in ALSPAC and UK Biobank; see ‘Statistical
analysis’ below) included: sex (UK Biobank only), age in
years, social class (0 ‘III manual skilled, IV and V unskilled
manual or casual workers or those who rely on state for
their income’ and 1 ‘I and II professional occupations and
managerial and technical occupations and III non-manual
skilled workers’43 (ALSPAC only); highest level of educa-
tion (0 ‘college degree or higher’ and 1 ‘A level equivalent
or lower’) (UK Biobank only); partner’s smoking (reported
by the mother) (0 ‘no’ and 1 ‘yes’) (ALSPAC only); part-
ner’s drinking (reported by the mother) (0 ‘never/very oc-
casionally’, 1 ‘occasionally’ and 2 ‘daily’) (ALSPAC only).
Genetic measures
Genotyping information for ALSPAC, HUNT, CGPS and
UK Biobank is provided in Supplementary Methods, avail-
able as Supplementary Data at IJE online. The rs1051730/
rs16969968 variants were used as a proxy for heaviness of
smoking (measured here as cigarettes per day) and were
coded 0, 1 and 2 for genotypes CC, CT and TT, respect-
ively. The minor allele frequency (MAF) was 0.33 for both
rs1051730 and rs16969968.
Statistical analysis
Linear regression was used to assess the association be-
tween cigarettes per day and units of alcohol per week [ad-
justed for age (both cohorts), social class, partner’s
smoking and drinking (ALSPAC only), sex and education
(UK Biobank only)] in ALSPAC and UK Biobank only.
Using data from ALSPAC and UK Biobank, we tested
the association between rs1051730/rs16969968 and cigar-
ettes per day as a test of the first assumption of MR (geno-
type must be associated with the exposure). We examined
associations between rs1051730/rs16969968 and con-
founders to test the third assumption of MR (that the gen-
etic instrument cannot be associated with any factors that
confound the relationship between the exposure and the
outcome). Both CGPS27 and HUNT28 have previously
published the association between rs16969968/rs1051730
and units of alcohol per week. The aim of these previous
analyses was not to assess the relationship between smok-
ing heaviness and alcohol consumption; however, both
tested the association between rs1051730 and alcohol con-
sumption as a test for genetic pleiotropy (i.e. considering
alcohol as a potential confounder in their analysis).
Additionally, these previous analysis have assessed the as-
sociation between rs1051730 and smoking behaviour and
a range of relevant confounders.27,28
Deviation from Hardy-Weinberg equilibrium was as-
sessed as a test of missingness that might arise from geno-
typing errors, clinical ascertainment or by chance.44
In each of the four cohorts (ALSPAC, HUNT, CGPS
and UK Biobank), units of alcohol per week (excluding
non-drinkers) (Supplementary Table 1, available as
Supplementary Data at IJE online) was standardized (i.e.
converted to a Z-score) for consistency between datasets.
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We then tested for association between rs1051730/
rs16969968 and standardized units per week stratified by
smoking status (current smokers/former smokers/never
smokers). Analysis in never and former smokers tests the
pleiotropy assumption of MR (i.e. the genotype cannot be
associated with the outcome through any other pheno-
type). Additional sensitivity analysis was conducted strat-
ifying the sample in ever smokers and never smokers.
We opted to use linear regression over two-stage least-
squares regression. This is because the second assumption
of MR (that the SNP should only be associated with the
outcome through the exposure of interest) is likely to be
violated when the phenotype (e.g. cigarettes per day) does
not adequately capture the exposure through which the
genetic variant operates. This has been described in detail
elsewhere.45,46 In brief, results from two-stage least-
squares regression may be biased when this assumption is
violated. In this situation, the genetic variant is still a valid
instrument to provide evidence of causality, but is not a
valid instrument for quantifying the effect of the measured
phenotype on the outcome. We assume a constant effect of
smoking on alcohol consumption and, as a result, we iden-
tify the average effect of smoking heaviness on alcohol con-
sumption in the sample.
The effect sizes between rs16969968/rs1051730 and
standardized units per week stratified by smoking status
for each study were pooled in a meta-analysis. We used
DerSimonian and Laird random-effects meta-analysis47
using the metan command in Stata 13.48,49
Quanto50 was used to calculate the sample size required
to obtain different effects in the MR analyses. A continu-
ous trait design was specified with a gene-only hypothesis,
using a desired power of 0.80, a significance level of 0.05
(two-sided) and a log additive mode of inheritance.
All analysis was carried out following STROBE
(Strengthening the Reporting of Observational Studies in
Epidemiology) guidelines (Supplementary Table 2, available
as Supplementary Data at IJE online). The Instrumental
Variable Checklist51 (Supplementary Table 3, available as
Supplementary Data at IJE online) was used for MR analysis
and the instrumental variable flow chart considered through-
out analyses and reporting.52
Results
Observational results
A total of 8030 individuals had genetic information col-
lected in ALSPAC and provided information on their smok-
ing status. Of these, 2198 (27.4%) were smokers and
provided information on alcohol consumption. The median
number of cigarettes per day and units of alcohol per week
were 15 (IQR ¼ 15) and 4 (IQR ¼ 3.5), respectively.
Following inclusion of covariate data, the sample size
for the complete case analysis was 1359 (Supplementary
Table 4, available as Supplementary Data at IJE online). In
UK Biobank, 335 921 individuals had genetic information
and provided data on their smoking status. Of these, 30 241
(9.0%) were smokers and provided information on alcohol
consumption. The median number of cigarettes per day and
units of alcohol per week were 15 (IQR ¼ 10) and 8
(IQR¼14), respectively. Following inclusion of covariate
data, the sample size for the complete case analysis was
15 323 (Supplementary Table 5, available as Supplementary
Data at IJE online).
There was strong evidence for an association between
cigarettes consumed per day and units of alcohol per week
[change in units per week for each additional cigarette per
day smoked ¼ 0.09, 95% confidence interval (CI) 0.04 to
0.15, P  0.001 in ALSPAC; and 0.65, 95% CI 0.61 to
0.69, P  0.001 in UK Biobank], which remained after ad-
justment for confounders (change in units per week for
each additional cigarette smoked ¼ 0.10, 95% CI 0.05 to
0.15, P  0.001 in ALSPAC; and 0.48, 95% CI 0.45 to
0.52, P  0.001 in UK Biobank) (Table 1).
MR results
In both ALSPAC and UK Biobank, there was evidence for
an association between rs1051730/rs16969968 and cigar-
ettes per day in those who smoked (change in cigarettes
smoked per day for each additional copy of the risk allele
¼ 0.91, 95% CI 0.41 to 1.40, P  0.001 in ALSPAC; and
0.95, 95% CI 0.79 to 1.12, P  0.001 in UK Biobank),
which is consistent with previous evidence that each
additional copy of the risk allele is responsible for an ap-
proximately one-cigarette-per-day increase in smoking
heaviness.25,26 There was no evidence for association be-
tween rs1051730/rs16969968 and potential confounding
factors in ALSPAC or UK Biobank (Supplementary
Tables 4 and 5, available as Supplementary Data at IJE on-
line) or a departure from Hardy-Weinberg equilibrium
(ALSPAC v2 P-value ¼ 0.34; HUNT v2 P-value ¼ 0.12;
CGPS v2 P-value ¼ 0.32; UK Biobank v2 P-value ¼ 0.89).
In total, 55 967 smokers were included when pooling
results from the ALSPAC, HUNT, CGPS and UK Biobank
studies. There was little evidence for an association be-
tween rs1051730/rs16969968 and units of alcohol per
week (where b coefficients represent the standard deviation
change for each additional copy of the risk allele) in never
(b ¼ –0.002, 95% CI –0.009 to 0.004, P ¼ 0.49), former
(b ¼ 0.002, 95% CI –0.005 to 0.010, P ¼ 0.55) or current
smokers (b ¼ –0.004, 95% CI –0.023 to 0.016, P ¼ 0.71)
(Figure 1). Additionally, there was little evidence for an
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association between rs16969968/rs1051730 and units of
alcohol per week in ever smokers (b ¼ 0.003, 95% CI
–0.004to 0.009, P ¼ 0.45) (Supplementary Figure 1, avail-
able as Supplementary Data at IJE online). In ALSPAC
and UK Biobank, MR results using all available data were
consistent with those using complete case data from the
observational analysis (Supplementary Table 6, available
as Supplementary Data at IJE online).
We calculated that our sample size of 55 967 current
smokers had at least 99% and 88% power to detect a change
of 0.03 and 0.02 standard deviations of units of alcohol per
additional copy of the minor allele, respectively.
Discussion
We corroborate the strong association between tobacco
and alcohol consumption in observational data sets using
ALSPAC and UK Biobank cohorts. However, we found
no clear evidence of a causal effect when using a genetic
marker of smoking heaviness in an MR framework using
current smokers from four European cohorts. Our ana-
lysis suggests that the reported associations between
smoking and alcohol could be strongly influenced by con-
founding factors and/or reverse causality, and that smok-
ing heaviness is not causally associated with alcohol
consumption.
Table 1. Unadjusted and adjusted effect sizes for observational analysis examining the association between cigarettes per day
and units of alcohol per week in ALSPAC and UK Biobank
Adjustment N Coef* 95% CI LR(v2) LR test P-value
ALSPAC
Unadjusted (all available data) 2198 0.11 0.07–0.16 23.02 0.001
Unadjusted (complete case analysis) 1359 0.09 0.04–0.15 12.01 0.001
Socio-economic position 1359 0.10 0.04–0.15 12.94 0.001
Age 1359 0.09 0.04–0.15 12.39 0.001
Partner’s smoking 1359 0.09 0.04–0.15 12.10 0.001
Partner’s drinking 1359 0.10 0.05–0.15 13.67 0.001
Fully Adjusted 1359 0.10 0.05–0.15 14.66 0.001
UK Biobank
Unadjusted (all available data) 15 462 0.65 0.61–0.69 1090.35 0.001
Unadjusted (complete case analysis) 15 323 0.65 0.61–0.69 1067.82 0.001
Education 15 323 0.65 0.61–0.69 1037.70 0.001
Age 15 323 0.65 0.61–0.69 1047.03 0.001
Sex 15 323 0.48 0.44–0.51 611.50 0.001
Fully adjusted 15 323 0.48 0.45–0.52 624.42 0.001
*Coefficients describe the increase in units of alcohol per week for each additional cigarette smoked per day. LR, likelihood ratio.
Figure 1. Effect sizes represent the standard deviation increase in units of alcohol per week for each additional copy of the minor (risk) allele.
P values for association in: never smokers = 0.496, former smokers = 0.549, current smokers = 0.708. Test of heterogeneity: never smokers I2 = 0.0%,
p = 0.558; former smokers I2=0.0%, p = 0.986; current smokers I2 = 51.9%, p= 0.101. Note: weights are from random effects meta-analysis.
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Two studies have assessed the relationship between to-
bacco and alcohol using MR. The results reported in this
manuscript are in agreement with Vrieze and colleagues,
who did not report an association.53 However, as the previ-
ous analysis uses an adolescent sample, the results may not
be comparable with an adult sample, such as those we re-
port here. Vink and colleagues reported that both cigarettes
per day and smoking cessation were associated with glasses
of alcohol per week when using polygenic risk scores as
proxies for smoking phenotypes.54 This analysis used weak
P-value thresholds to generate their polygenic risk scores
and therefore provide evidence for shared aggregated gen-
etic risk factors between tobacco and alcohol use, rather
than testing for a causal relationship. Following meta-
analysis of data from four studies, the sample size of the
analysis we report here increased to 55 967 and is therefore
much larger than that reported by Vink and colleagues,
providing more robust evidence for no causal association
between heaviness of smoking and alcohol consumption.
As alcohol consumption does not remain stable over
time, smoking may have a causal effect on levels of alcohol
consumption regardless of when people start drinking.
Here, we have examined the dose—response relationship
between heaviness of smoking among current smokers
with levels of alcohol consumption, not the effect of smok-
ing initiation on subsequent alcohol use. By examining this
using MR, our results cannot be influenced by reverse
causation. One study conducted by Irons and colleagues
(2007) examined the causal effect of alcohol use on to-
bacco use using MR finding little evidence for an effect.55
This study, in conjunction with the results reported here,
provides evidence that previously reported associations be-
tween tobacco and alcohol use are not the result of reverse
causation and that confounding factors are responsible for
the co-occurrence of these substances.
A number of limitations need to be considered when inter-
preting these results. First, when excluding women with miss-
ing data on all genetic, outcome, exposure and covariate
measures, there is a large amount of attrition from the ori-
ginal ALSPAC dataset. Second, both smoking and alcohol
consumption in this study were assessed using self-report.
The potential effect of this limitation is reduced by the use of
a genetic variant as a determinant of smoking, as it is unlikely
to vary with regard to reporting bias. Nevertheless, biological
assessment at least for tobacco use (based on cotinine data
for smoking) would be advantageous in any further studies.56
However, alcohol biomarkers for chronic consumption are
unreliable.57 Third, it is likely that MR analysis is underpow-
ered to rule out any association between tobacco and alcohol.
We would not expect to see the same effect size between the
non-genetic observational analysis and the MR analysis (since
the genetic variants only explain a small proportion of the
variance in heaviness of smoking). However, as the observed
effects are very close to the null, the conclusion can be made
that the MR result is consistent with a null result.
Furthermore, the meta-analysis of results with those from the
HUNT and CGPS cohorts provide further evidence that is
consistent with the null hypothesis. Fourth, the design of MR
and meta-analysis are susceptible to population stratification.
There is potential for population stratification between each
of the datasets used. However, the effect in each of these stud-
ies has been examined separately and no difference was
observed, suggesting it is reasonable to conclude that popula-
tion stratification is not affecting these results. We did observe
heterogeneity between the observational results in ALSPAC
and UK Biobank, but the direction of the association was
consistent. The differences in the magnitude of the association
could be explained by differences in age and gender between
the two populations, the fact that the data were collected
15 years apart or that the ALSPAC sample comprised indi-
viduals who might have been trying to get pregnant at the
time. Finally, we cannot completely rule out the possibility
that collider bias may affect these results. As the genetic vari-
ant influences likelihood of smoking cessation,58 stratifying
analyses into former and current smokers could induce col-
lider bias. However, there is little evidence to suggest that the
variant influences smoking initiation, so stratification of re-
sults into ever and never smokers should be less problematic.
Furthermore, collider bias could also arise if selection into the
study samples is related to both alcohol consumption and
rs16969968/rs1051730 (if heavier smoking makes individuals
less likely to participate). This is most likely to be an issue in
UK Biobank, which has very low participation rates and is
not likely to be very representative of individuals of the target
age group living in the UK.59 When excluding UK Biobank
from the meta-analysis, results remained the same
(Supplementary Figure 2, available as Supplementary Data at
IJE online).
MR techniques are particularly pertinent to behavioural
exposures—such as tobacco smoking, alcohol consump-
tion, cannabis and other drug use—which cannot be ran-
domized, cluster with other risk behaviours and
confounders, and lack effective interventions that could be
used in trials that randomize the removal of the exposure.
We find no clear evidence for the prevailing assumption
that tobacco causally affects alcohol consumption, which
has great implications for public health and intervention
research. Interventions that target reductions in tobacco
consumption may not necessarily also lead to any change
in alcohol consumption, and interventions that seek to tar-
get both smoking and alcohol will need to incorporate ac-
tive ingredients for each substance.
Supplementary Data
Supplementary data are available at IJE online.
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